Investors might be tempted to characterize Friday's jobs report, and the ensuing stock-market reaction, as another example of the "good news is bad news" dynamic: good news for the economy tends to be ...
U.S. stock futures leaned lower Friday on concern over possible export restrictions on Nvidia, ahead of key data on the jobs ...
The share price of Nvidia has formed a promising pattern likely to anchor news highs as the stock seeks to reclaim the $140 ...
While Palantir's surge this year is certainly impressive, the stock's valuation seems to have become detached from the underlying business. The chart below shows the company's price-to-sales ratio ...
After he credited AI with the company's growth in the fiscal third quarter of 2025 (ended Oct. 31), the stock shot 25% higher following the announcement and has held on to most of those gains.
During the trading hours on Thursday, Quantum Computing (QUBT, Financial) stock declined by about 40%. This comes after the stock has run up 578% in recent weeks on the back of buying into quantum ...
The Indian stock market benchmark ... negative candle on the daily chart with upper shadow, which is indicating a sharp reversal in the market after the upside bounce. “The last three sessions ...
Micron shares, which closed 4.33% lower in the New York Stock Exchange regular session on the second-quarter earnings report below market forecasts, also plunged more than 13% in after-hours ...
A lot is riding on it, particularly after expectations for a series of cuts in 2025 helped the U.S. stock market set an all-time high 57 times so far in 2024. Fed officials released projections on ...
The chart below shows a sharp drop in stocks on the New York Stock Exchange that are hitting peak prices. About 474 stocks made new highs on the New York Stock Exchange the day after the election ...
Textile stocks are breaking out on the charts with robust volume patterns, drawing attention from technical analysts. While the National Stock Exchange (NSE) and BSE do not offer a sectoral index ...
ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket on Tuesday after the companies said that their experimental antibody therapy, duvakitug, reached the ...